These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15187645)

  • 21. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
    Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
    Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant factor VIIa (Novoseven) and the safety of treatment.
    Roberts HR
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):48-50. PubMed ID: 11735111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant activated factor VII and perioperative blood loss.
    Williams D; McCarthy R
    Lancet; 2003 May; 361(9370):1745; author reply 1745-6. PubMed ID: 12767766
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant activated factor VII and perioperative blood loss.
    Volk T; von Heymann C; Kox WJ
    Lancet; 2003 May; 361(9370):1745; author reply 1745-6. PubMed ID: 12767765
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.
    Grounds RM; Bolan C
    Crit Care; 2005; 9 Suppl 5(Suppl 5):S29-36. PubMed ID: 16221317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Massive transfusion coagulopathy.
    Levy JH
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S59-63. PubMed ID: 16427387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy.
    Schmid S; Friesenecker B; Lorenz I; Innerhofer P; Koscielny J; Velik-Salchner C; Mutz N; Fries D
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):313-7. PubMed ID: 17636194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of recombinant activated coagulation factor VII for spine surgery.
    Weiskopf RB
    Eur Spine J; 2004 Oct; 13 Suppl 1(Suppl 1):S83-8. PubMed ID: 15160317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of off-label recombinant activated factor VII for multiple indications in children.
    Reiter PD; Valuck RJ; Taylor RS
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):233-40. PubMed ID: 17636185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors.
    O'Connell N; Mc Mahon C; Smith J; Khair K; Hann I; Liesner R; Smith OP
    Br J Haematol; 2002 Mar; 116(3):632-5. PubMed ID: 11849223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.
    Brinkhous KM; Hedner U; Garris JB; Diness V; Read MS
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1382-6. PubMed ID: 2784006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.
    Martinowitz U; Michaelson M;
    J Thromb Haemost; 2005 Apr; 3(4):640-8. PubMed ID: 15842347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful use of activated recombinant factor VII in life threatening bleeding after thoracic surgery.
    Kogler VM; Slobodnjak Z; Samarzija M; Macan JS; Karadza V; Jakopovic M
    Swiss Med Wkly; 2007 Jul; 137(27-28):407-10. PubMed ID: 17705102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
    Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant activated factor VII for non-hemophiliac bleeding patients.
    Uhlmann EJ; Eby CS
    Curr Opin Hematol; 2004 May; 11(3):198-204. PubMed ID: 15257021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial.
    Raobaikady R; Redman J; Ball JA; Maloney G; Grounds RM
    Br J Anaesth; 2005 May; 94(5):586-91. PubMed ID: 15734783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant activated factor VII following pediatric cardiac surgery.
    Kylasam S; Mos K; Fijtin S; Webster B; Chard R; Egan J
    J Intensive Care Med; 2009; 24(2):116-21. PubMed ID: 19188273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant factor VIIa for intraoperative bleeding in a child with hepatoblastoma and review of recombinant activated factor VIIa use in children undergoing surgery.
    Al-Said K; Anderson R; Wong A; Le D
    J Pediatr Surg; 2008 Apr; 43(4):e15-9. PubMed ID: 18405694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
    Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.